Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 607

1.

Neoadjuvant Three-Dimensional Conformal Radiotherapy for Resectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Randomized, Open-Label, Multicenter Controlled Study.

Wei X, Jiang Y, Zhang X, Feng S, Zhou B, Ye X, Xing H, Xu Y, Shi J, Guo W, Zhou D, Zhang H, Sun H, Huang C, Lu C, Zheng Y, Meng Y, Huang B, Cong W, Lau WY, Cheng S.

J Clin Oncol. 2019 Jul 8:JCO1802184. doi: 10.1200/JCO.18.02184. [Epub ahead of print]

PMID:
31283409
2.

Impact of postoperative infective complications on long-term survival after liver resection for hepatocellular carcinoma.

Yang T, Liu K, Liu CF, Zhong Q, Zhang J, Yu JJ, Liang L, Li C, Wang MD, Li ZL, Wu H, Xing H, Han J, Lau WY, Zeng YY, Zhou YH, Gu WM, Wang H, Chen TH, Zhang YM, Zhang WG, Pawlik TM, Wu MC, Shen F.

Br J Surg. 2019 Aug;106(9):1228-1236. doi: 10.1002/bjs.11231. Epub 2019 Jul 5.

PMID:
31276196
3.

Antiviral therapy improves post-operative survival outcomes in patients with HBV-related hepatocellular carcinoma of less than 3 cm - A retrospective cohort study.

Wang ZY, Tao QF, Wang ZH, Lin KY, Huang G, Yang Y, Zhou WP, Lau WY.

Am J Surg. 2019 Jun 13. pii: S0002-9610(18)31609-X. doi: 10.1016/j.amjsurg.2019.05.016. [Epub ahead of print]

PMID:
31266631
4.

Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) and its further developments in the last decade.

Lau WY.

Hepatobiliary Surg Nutr. 2019 Jun;8(3):258-259. doi: 10.21037/hbsn.2019.05.01. No abstract available.

5.

A Pretreatment CT Model Predicts Survival Following Chemolipiodolization in Patients With Hepatocellular Carcinoma.

Zhang Y, Qu S, Yi W, Zhai J, Zhang X, Wei L, Lau WY, Wu M, Shen F, Fan H, Wu D.

Technol Cancer Res Treat. 2019 Jan 1;18:1533033819844488. doi: 10.1177/1533033819844488.

6.

Postoperative adjuvant IMRT for patients with HCC and portal vein tumor thrombus: An open-label randomized controlled trial.

Sun J, Yang L, Shi J, Liu C, Zhang X, Chai Z, Lau WY, Meng Y, Cheng SQ.

Radiother Oncol. 2019 Jun 5;140:20-25. doi: 10.1016/j.radonc.2019.05.006. [Epub ahead of print]

PMID:
31176205
7.

Tissue-infiltrating lymphocytes signature predicts survival in patients with early/intermediate stage hepatocellular carcinoma.

Tian MX, Liu WR, Wang H, Zhou YF, Jin L, Jiang XF, Tao CY, Tang Z, Zhou PY, Fang Y, Qu WF, Ding ZB, Peng YF, Dai Z, Qiu SJ, Zhou J, Lau WY, Fan J, Shi YH.

BMC Med. 2019 Jun 5;17(1):106. doi: 10.1186/s12916-019-1341-6.

8.

Postoperative adjuvant sorafenib improves survival outcomes in hepatocellular carcinoma patients with microvascular invasion after R0 liver resection: a propensity score matching analysis.

Zhang XP, Chai ZT, Gao YZ, Chen ZH, Wang K, Shi J, Guo WX, Zhou TF, Ding J, Cong WM, Xie D, Lau WY, Cheng SQ.

HPB (Oxford). 2019 May 29. pii: S1365-182X(19)30535-0. doi: 10.1016/j.hpb.2019.04.014. [Epub ahead of print]

PMID:
31153833
9.

Extra-Glissonian Approach for Laparoscopic Liver Right Anterior Sectionectomy.

Chen HW, Wang FJ, Li JY, Deng FW, Lai ECH, Lau WY.

JSLS. 2019 Apr-Jun;23(2). pii: e2019.00009. doi: 10.4293/JSLS.2019.00009.

10.

An Eastern Hepatobiliary Surgery Hospital Microvascular Invasion Scoring System in Predicting Prognosis of Patients with Hepatocellular Carcinoma and Microvascular Invasion After R0 Liver Resection: A Large-Scale, Multicenter Study.

Zhang XP, Wang K, Wei XB, Li LQ, Sun HC, Wen TF, Chai ZT, Chen ZH, Shi J, Guo WX, Xie D, Cong WM, Wu MC, Lau WY, Cheng SQ.

Oncologist. 2019 May 28. pii: theoncologist.2018-0868. doi: 10.1634/theoncologist.2018-0868. [Epub ahead of print]

PMID:
31138726
11.

Long-Term Survival Outcomes After Liver Resection for Binodular Hepatocellular Carcinoma: A Multicenter Cohort Study.

Wang MD, Li C, Li J, Zhang WG, Jiang WQ, Yu JJ, Xing H, Wu H, Han J, Li ZL, Xu XF, Chen TH, Zhou YH, Gu WM, Wang H, Zeng YY, Zhang YM, Pawlik TM, Lau WY, Wu MC, Yang JM, Shen F, Yang T.

Oncologist. 2019 May 24. pii: theoncologist.2018-0898. doi: 10.1634/theoncologist.2018-0898. [Epub ahead of print]

PMID:
31127021
12.

Robotic versus laparoscopic liver resection in complex cases of left lateral sectionectomy.

Hu M, Liu Y, Li C, Wang G, Yin Z, Lau WY, Liu R.

Int J Surg. 2019 Jul;67:54-60. doi: 10.1016/j.ijsu.2019.05.008. Epub 2019 May 20.

PMID:
31121328
13.

Association of family history with long-term prognosis in patients undergoing liver resection of HBV-related hepatocellular carcinoma.

Li ZL, Han J, Liu K, Xing H, Wu H, Lau WY, Pawlik TM, Li C, Wang MD, Yu JJ, Wu MC, Shen F, Yang T.

Hepatobiliary Surg Nutr. 2019 Apr;8(2):88-100. doi: 10.21037/hbsn.2018.11.20.

14.

Transarterial chemoembolization versus best supportive care for patients with hepatocellular carcinoma with portal vein tumor thrombus:a multicenter study.

Xiang X, Lau WY, Wu ZY, Zhao C, Ma YL, Xiang BD, Zhu JY, Zhong JH, Li LQ.

Eur J Surg Oncol. 2019 Apr 12. pii: S0748-7983(19)30387-7. doi: 10.1016/j.ejso.2019.03.042. [Epub ahead of print]

PMID:
31005471
15.

A nomogram to predict early postoperative recurrence of hepatocellular carcinoma with portal vein tumour thrombus after R0 liver resection: A large-scale, multicenter study.

Zhang XP, Chen ZH, Zhou TF, Li LQ, Chen MS, Wen TF, Shi J, Guo WX, Wu MC, Lau WY, Cheng SQ; Chinese National Research Cooperative Group for Diagnosis and Treatment of Hepatocellular Carcinoma with Tumour Thrombus.

Eur J Surg Oncol. 2019 Apr 3. pii: S0748-7983(19)30388-9. doi: 10.1016/j.ejso.2019.03.043. [Epub ahead of print]

PMID:
30982657
16.

An end-to-end pancreatic anastomosis in robotic central pancreatectomy.

Wang ZZ, Zhao GD, Zhao ZM, Gao YX, Xu Y, Yin ZZ, Liu Q, Lau WY, Liu R.

World J Surg Oncol. 2019 Apr 13;17(1):67. doi: 10.1186/s12957-019-1609-5.

17.

Water intake after dehydration makes muscles more susceptible to cramp but electrolytes reverse that effect.

Lau WY, Kato H, Nosaka K.

BMJ Open Sport Exerc Med. 2019 Mar 5;5(1):e000478. doi: 10.1136/bmjsem-2018-000478. eCollection 2019. Erratum in: BMJ Open Sport Exerc Med. 2019 Apr 11;5(1):e000478corr1.

18.

Extended Experience in the Use of Antibiotic Lock for Eradication of Biofilm Bacteria on Tenckhoff Catheter.

Wong SS, Lau WY, Chan PK, Wan CK, Cheng YL.

Perit Dial Int. 2019 Mar-Apr;39(2):187-190. doi: 10.3747/pdi.2018.00098.

PMID:
30858288
19.

Impact of Anatomical Versus Non-anatomical Liver Resection on Short- and Long-Term Outcomes for Patients with Intrahepatic Cholangiocarcinoma.

Si A, Li J, Yang Z, Xia Y, Yang T, Lei Z, Cheng Z, Pawlik TM, Lau WY, Shen F.

Ann Surg Oncol. 2019 Jun;26(6):1841-1850. doi: 10.1245/s10434-019-07260-8. Epub 2019 Mar 6.

PMID:
30843164
20.

Hydrochloric acid enhanced radiofrequency ablation for treatment of large hepatocellular carcinoma in the caudate lobe: Report of three cases.

Deng HX, Huang JH, Lau WY, Ai F, Chen MS, Huang ZM, Zhang TQ, Zuo MX.

World J Clin Cases. 2019 Feb 26;7(4):508-515. doi: 10.12998/wjcc.v7.i4.508.

Supplemental Content

Loading ...
Support Center